Research & Development

青娱乐福利在线2青娱乐视频分类精品国产青娱乐?在线极品盛宴科创板开市在即投资要看增长率 请收好这份清单


  雲瑯站在二樓上,瞅著這些激動地婦人,不由得有些慚愧。   阿嬌現在就盯著小蟲的屁股看,怎麼看怎麼覺得小蟲身上的游泳衣很好看,就那麼幾片布,就把女人最美的身段顯露無遺。青娱乐福利在线2 第一六一章 安寧的日子青娱乐视频分类精品国产   “你耍賴,不準在水桶里流眼淚……”曹襄帶著哭腔怒吼道。   曹襄端著飯盆抽抽鼻子道︰“我家的家僕也比東方朔富裕一些,那個女人正無處可去呢,有人接手,而且家境不錯,自然就跟著走了。”青娱乐?在线极品盛宴   雲瑯小聲道︰“留著力氣應對今日的考驗吧,我估計今天的操練一定比昨日更狠!”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo